OFIX Q2 2023 Earnings — Orthofix Medical Inc. Revenue & Financial Results | Market Cap Arena

OFIXOrthofix Medical Inc.

$503M

Q2 2023 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$187M+58.4% YoY

Gross Profit

$120M63.9% margin

Operating Income

-$37M-19.6% margin

Net Income

-$39M-21.1% margin

EPS (Diluted)

$-1.07

QoQ Revenue Growth

+6.7%

Cash Flow

Operating Cash Flow

-$6M

Free Cash Flow

-$18M

Stock-Based Comp.

$13M

Balance Sheet

Total Assets

$901M

Total Liabilities

$261M

Stockholders' Equity

$640M

Cash & Equivalents

$38M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$187M	$118M	+58.4%
Gross Profit	$120M	$86M	+38.3%
Operating Income	-$37M	$7M	-651.6%
Net Income	-$39M	$2M	-1684.0%

Revenue Segments

Global Spine

$158M66%

Bone Growth Therapies

$53M22%

Global Orthopedics

$29M12%

Geographic Segments

Global Spine

$158M75%

Bone Growth Therapies

$53M25%